Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma-Reference-Cited by-同舟云学术

Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma

Published:2022-03-03 Issue:7 Volume:65 Page:5374-5391
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chen Xiaojing¹,Liu Lu¹,Liu Peng¹,Chen Yingying¹,Lin Dan²,Yan Hao¹,Yan Qi¹,Wang Yi¹,Qiu Yinda¹,Fang Bo¹^ORCID,Huang Huijing¹,Qian Jianchang¹,Zhao Yunjie¹,Du Zhou³,Zhang Qianwen¹,Li Xiaokun¹,Zheng Xiaohui¹,Liu Zhiguo¹^ORCID

Affiliation:

1. Chemical Biology Research Center at School of Pharmaceutical Sciences, Wenzhou Medical University, 1210 University Town, Wenzhou, Zhejiang 325035, People’s Republic of China

2. The Eye Hospital, School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of China

3. Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, People’s Republic of China

Funder

Wenzhou Medical University

National Natural Science Foundation of China

Natural Science Foundation of Zhejiang Province

Wenzhou Basic Medical and Health Technology Project

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link